Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults
- 14 January 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical Research in Cardiology
- Vol. 97 (5), 318-326
- https://doi.org/10.1007/s00392-007-0633-6
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart FailureCirculation, 2007
- TrpC3 Regulates Hypertrophy-Associated Gene Expression without Affecting Myocyte Beating or Cell SizePLOS ONE, 2007
- Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia CellsPLOS ONE, 2007
- Tbx2 and Tbx3 Regulate the Dynamics of Cell Proliferation during Heart RemodelingPLOS ONE, 2007
- Increased Expression of the Auxiliary β2-subunit of Ventricular L-type Ca2+ Channels Leads to Single-Channel Activity Characteristic of Heart FailurePLOS ONE, 2007
- Cardiovascular Complications of Cancer TherapyCirculation, 2004
- Anthracycline-induced cardiomyopathySeminars in Oncology, 2001
- Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapyJournal of the American College of Cardiology, 2000
- Cardiotoxicity of Chemotherapeutic AgentsDrug Safety, 2000
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978